S. Baxi

A phase II study of temsirolimus added to low-dose weekly carboplatin and paclitaxel for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

N. Katabi, A. Ho, D. Pfister, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.

J. Machiels, T. Seiwert, A. Psyrri, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.

C. Antonescu, S. Dogan, N. Katabi, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Oncologist use and perception of large panel next-generation tumor sequencing

D. M. Hyman, J. Galle, N. Schultz, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.